US Edition
Doliprane Recall: 20 Batches of Children’s Pain Relief Pulled
11 Articles
11 Articles
About 20 lots of "Doliprane 2.4%", used for infants and young children, must be recalled, announced the ANSM on Monday. The marking of some pipettes would erase washing under warm or lukewarm water, putting the risk of overdose.
"Graduations of pipettes in certain vials may be phased out after a warm or hot water rinse," explains the National Agency for the Safety of Medicines and Health Products (ANSM).
A national recall targets 27 lots of Doliprane 2.4% for infants and young children, due to a dosing pipette whose graduations are effaced. How do I know if your vials are affected and what risks this...
LANSM announces the recall of 27 lots of Doliprane 2.4% for infants and young children due to a pipette defect that may lead to a risk of overdose.
The problem comes from the dosing pipettes delivered with the medicine. The patients concerned are asked to bring the product back to their pharmacist. - Doliprane: reminder of oral suspension vials intended for children (Health and well-being).
The manufacturer recalls certain consignments of Doliprane for children due to the removal of pipette graduations.
Coverage Details
Bias Distribution
- 57% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
